Replies to post #675624 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

DD was speaking about the phase I study, I believe. You are discussing the phase II study.

BS.

DD stated "the poly iclc combo trial". That phrase has always been taken as the recently completed trial, not this P1 that had 3 patients who used PolyICLC.

Obviously NWBO has worked with UCLA in the past.